BlackRock’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $250M | Buy |
13,034,434
+319,233
| +3% | +$6.35M | ﹤0.01% | 1531 |
|
|
2025
Q4 | $210M | Buy |
12,715,201
+425,575
| +3% | +$7.18M | ﹤0.01% | 1653 |
|
|
2025
Q3 | $178M | Buy |
12,289,626
+236,281
| +2% | +$3.4M | ﹤0.01% | 1729 |
|
|
2025
Q2 | $169M | Sell |
12,053,345
-1,781,611
| -13% | -$25.1M | ﹤0.01% | 1727 |
|
|
2025
Q1 | $188M | Sell |
13,834,956
-85,289
| -0.6% | -$1.63M | ﹤0.01% | 1632 |
|
|
2024
Q4 | $284M | Buy |
13,920,245
+131,728
| +1% | +$3.37M | 0.01% | 1448 |
|
|
2024
Q3 | $402M | Buy |
13,788,517
+613,955
| +5% | +$15.2M | 0.01% | 1227 |
|
|
2024
Q2 | $306M | Buy |
13,174,562
+974,706
| +8% | +$18.7M | 0.01% | 1337 |
|
|
2024
Q1 | $250M | Buy |
12,199,856
+656,410
| +6% | +$12.3M | 0.01% | 1495 |
|
|
2023
Q4 | $248M | Buy |
11,543,446
+658,150
| +6% | +$13M | 0.01% | 1511 |
|
|
2023
Q3 | $225M | Buy |
10,885,296
+779,021
| +8% | +$19.8M | 0.01% | 1455 |
|
|
2023
Q2 | $298M | Buy |
10,106,275
+631,878
| +7% | +$17.8M | 0.01% | 1304 |
|
|
2023
Q1 | $218M | Buy |
9,474,397
+152,383
| +2% | +$4.19M | 0.01% | 1479 |
|
|
2022
Q4 | $259M | Buy |
9,322,014
+723,802
| +8% | +$21.5M | 0.01% | 1340 |
|
|
2022
Q3 | $264M | Sell |
8,598,212
-186,420
| -2% | -$6.06M | 0.01% | 1265 |
|
|
2022
Q2 | $259M | Buy |
8,784,632
+598,892
| +7% | +$15.7M | 0.01% | 1337 |
|
|
2022
Q1 | $263M | Buy |
8,185,740
+74,918
| +0.9% | +$2.58M | 0.01% | 1463 |
|
|
2021
Q4 | $362M | Buy |
8,110,822
+549,985
| +7% | +$26.1M | 0.01% | 1276 |
|
|
2021
Q3 | $381M | Buy |
7,560,837
+524,796
| +7% | +$29.6M | 0.01% | 1207 |
|
|
2021
Q2 | $552M | Buy |
7,036,041
+471,589
| +7% | +$29.2M | 0.02% | 945 |
|
|
2021
Q1 | $375M | Buy |
6,564,452
+188,374
| +3% | +$12.6M | 0.01% | 1269 |
|
|
2020
Q4 | $534M | Buy |
6,376,078
+290,761
| +5% | +$17.6M | 0.02% | 847 |
|
|
2020
Q3 | $218M | Sell |
6,085,317
-172,265
| -3% | -$5.19M | 0.01% | 1316 |
|
|
2020
Q2 | $151M | Buy |
6,257,582
+991,226
| +19% | +$23.3M | 0.01% | 1560 |
|
|
2020
Q1 | $92.2M | Buy |
5,266,356
+18,778
| +0.4% | +$392K | ﹤0.01% | 1697 |
|
|
2019
Q4 | $91.4M | Buy |
5,247,578
+669
| +0% | +$11.1K | ﹤0.01% | 2024 |
|
|
2019
Q3 | $80.4M | Buy |
5,246,909
+92,812
| +2% | +$1.77M | ﹤0.01% | 2020 |
|
|
2019
Q2 | $107M | Buy |
5,154,097
+604,766
| +13% | +$13.6M | ﹤0.01% | 1863 |
|
|
2019
Q1 | $106M | Sell |
4,549,331
-23,364
| -0.5% | -$489K | ﹤0.01% | 1839 |
|
|
2018
Q4 | $94.5M | Buy |
4,572,695
+1,265,645
| +38% | +$23M | ﹤0.01% | 1840 |
|
|
2018
Q3 | $71.9M | Buy |
3,307,050
+2,185,692
| +195% | +$36.2M | ﹤0.01% | 2183 |
|
|
2018
Q2 | $17.1M | Buy |
1,121,358
+67,420
| +6% | +$1.27M | ﹤0.01% | 2950 |
|
|
2018
Q1 | $20.8M | Buy |
+1,053,938
| New | +$21.7M | ﹤0.01% | 2754 |
|
Other funds holding DNLI
VCM
VPM
BBA